AU2001294577A1 - Methods for preparing interferon producing dentitric cells - Google Patents
Methods for preparing interferon producing dentitric cellsInfo
- Publication number
- AU2001294577A1 AU2001294577A1 AU2001294577A AU9457701A AU2001294577A1 AU 2001294577 A1 AU2001294577 A1 AU 2001294577A1 AU 2001294577 A AU2001294577 A AU 2001294577A AU 9457701 A AU9457701 A AU 9457701A AU 2001294577 A1 AU2001294577 A1 AU 2001294577A1
- Authority
- AU
- Australia
- Prior art keywords
- dentitric
- cells
- methods
- interferon producing
- preparing interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/52—CD40, CD40-ligand (CD154)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23414200P | 2000-09-21 | 2000-09-21 | |
US60/234,142 | 2000-09-21 | ||
PCT/US2001/029065 WO2002024874A2 (en) | 2000-09-21 | 2001-09-18 | Methods for preparing interferon producing dentitric cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001294577A1 true AU2001294577A1 (en) | 2002-04-02 |
Family
ID=22880117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001294577A Abandoned AU2001294577A1 (en) | 2000-09-21 | 2001-09-18 | Methods for preparing interferon producing dentitric cells |
Country Status (3)
Country | Link |
---|---|
US (2) | US6660523B2 (en) |
AU (1) | AU2001294577A1 (en) |
WO (1) | WO2002024874A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100536919C (en) * | 2001-01-09 | 2009-09-09 | 贝勒研究院 | Interferon antagon and usage of Flt3L antagon |
AU2002951082A0 (en) * | 2002-08-30 | 2002-09-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic cellular agents |
CN1993460A (en) * | 2004-07-12 | 2007-07-04 | 索林集团意大利有限公司 | Device and method for cultivating human cell |
WO2006086586A2 (en) * | 2005-02-10 | 2006-08-17 | Baylor Research Institute | Anti-interferon alpha monoclonal antibodies and methods for use |
US7888481B2 (en) * | 2005-02-10 | 2011-02-15 | Baylor Research Institute | Anti-interferon alpha monoclonal antibodies and methods for use |
US7919265B2 (en) * | 2006-06-21 | 2011-04-05 | Children's Research Institute | Antibody-based method for isolating Th1 and Th2 helper lymphocytes from human peripheral blood |
CN101182509A (en) * | 2006-11-10 | 2008-05-21 | 李炯明 | Solid phase t cell selection used for antigenic specificity t cell purification |
WO2009111396A1 (en) * | 2008-03-03 | 2009-09-11 | University Of Toledo | Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof |
RU2532832C2 (en) * | 2008-05-07 | 2014-11-10 | Аргос Терапьютикс, Инк. | Humanised antibodies against human alpha interferon |
WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
CN106715676A (en) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | Scheduled feed |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
CN109415696A (en) | 2016-05-25 | 2019-03-01 | 泰尔茂比司特公司 | Cell amplification |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
EP3601521A2 (en) | 2017-03-31 | 2020-02-05 | Terumo BCT, Inc. | Cell expansion |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877289A (en) * | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
CA2318819A1 (en) * | 1998-02-05 | 1999-08-12 | Novartis Ag | Expanded and genetically modified populations of human hematopoietic stem cells |
NZ513303A (en) | 1999-02-04 | 2003-03-28 | Technion Res & Dev Foundation | Three dimensional plug flow bioreactor, and its use for the maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
US6472208B1 (en) * | 1999-12-13 | 2002-10-29 | Héma-Québec | Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells |
-
2001
- 2001-09-18 WO PCT/US2001/029065 patent/WO2002024874A2/en active Application Filing
- 2001-09-18 US US09/954,905 patent/US6660523B2/en not_active Expired - Fee Related
- 2001-09-18 AU AU2001294577A patent/AU2001294577A1/en not_active Abandoned
-
2003
- 2003-10-09 US US10/682,666 patent/US6913924B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020098587A1 (en) | 2002-07-25 |
US6913924B2 (en) | 2005-07-05 |
WO2002024874A2 (en) | 2002-03-28 |
WO2002024874A3 (en) | 2003-02-13 |
US20040071662A1 (en) | 2004-04-15 |
US6660523B2 (en) | 2003-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002357049A1 (en) | Methods for preparing 0-desmethylvenlafaxine | |
AU2001294198A1 (en) | Cells producing antibody compositions | |
AU2001294577A1 (en) | Methods for preparing interferon producing dentitric cells | |
AU2001227947A1 (en) | Polycarbonate preparation process | |
AU7950400A (en) | Process for producing polypeptide | |
AU2001271021A1 (en) | Process for producing glycoprotein | |
AU2002217089A1 (en) | Method for producing sulfonamide-substituted imidazotriazinones | |
AU2001291882A1 (en) | Method for producing polyisobutylphenols | |
AU2406001A (en) | Method for preparing glass-ceramic | |
AU2001258734A1 (en) | Mould for curved panels | |
AU2001290321A1 (en) | Method of producing fuel cell | |
GB0029781D0 (en) | Methods for producing novel enzymes | |
AU2001242735A1 (en) | Process for producing camptothecin | |
AU2001230601A1 (en) | Method for producing ceramic structure | |
AU2002212224A1 (en) | Method for producing delta1-pyrrolines | |
AU2001280244A1 (en) | Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine | |
AUPR095200A0 (en) | Cell production | |
AU2001269501A1 (en) | Process for producing 2-hydroxy-4-methylthiobutanoic acid | |
AU2001260605A1 (en) | Process for producing antioxidant | |
AU1283001A (en) | Method for producing alkylhalogenosilanes | |
AU2612000A (en) | Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells | |
AU2001254841A1 (en) | Process for producing ether | |
AU2001296023A1 (en) | Process for producing peptide | |
AU2001284442A1 (en) | Process for producing fluoroalkanol | |
AU2001262147A1 (en) | Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene |